DBVT
Price
$9.87
Change
-$0.08 (-0.80%)
Updated
Sep 12 closing price
Capitalization
262.57M
PASG
Price
$7.00
Change
+$0.03 (+0.43%)
Updated
Sep 12 closing price
Capitalization
22.25M
64 days until earnings call
Interact to see
Advertisement

DBVT vs PASG

Header iconDBVT vs PASG Comparison
Open Charts DBVT vs PASGBanner chart's image
DBV Technologies S.A
Price$9.87
Change-$0.08 (-0.80%)
Volume$18.28K
Capitalization262.57M
Passage Bio
Price$7.00
Change+$0.03 (+0.43%)
Volume$66.89K
Capitalization22.25M
DBVT vs PASG Comparison Chart in %
Loading...
DBVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PASG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DBVT vs. PASG commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBVT is a StrongBuy and PASG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 15, 2025
Stock price -- (DBVT: $9.87 vs. PASG: $7.00)
Brand notoriety: DBVT and PASG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DBVT: 60% vs. PASG: 101%
Market capitalization -- DBVT: $262.57M vs. PASG: $22.25M
DBVT [@Biotechnology] is valued at $262.57M. PASG’s [@Biotechnology] market capitalization is $22.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DBVT’s FA Score shows that 0 FA rating(s) are green whilePASG’s FA Score has 1 green FA rating(s).

  • DBVT’s FA Score: 0 green, 5 red.
  • PASG’s FA Score: 1 green, 4 red.
According to our system of comparison, PASG is a better buy in the long-term than DBVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DBVT’s TA Score shows that 6 TA indicator(s) are bullish while PASG’s TA Score has 5 bullish TA indicator(s).

  • DBVT’s TA Score: 6 bullish, 3 bearish.
  • PASG’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, DBVT is a better buy in the short-term than PASG.

Price Growth

DBVT (@Biotechnology) experienced а +10.08% price change this week, while PASG (@Biotechnology) price change was -2.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.38%. For the same industry, the average monthly price growth was +7.84%, and the average quarterly price growth was +35.14%.

Reported Earning Dates

PASG is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+1.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DBVT($263M) has a higher market cap than PASG($22.3M). DBVT YTD gains are higher at: 219.417 vs. PASG (-38.282). PASG has higher annual earnings (EBITDA): -52.49M vs. DBVT (-115.51M). DBVT has more cash in the bank: 103M vs. PASG (57.6M). DBVT has less debt than PASG: DBVT (8.29M) vs PASG (24.7M). DBVT (0) and PASG (0) have equivalent revenues.
DBVTPASGDBVT / PASG
Capitalization263M22.3M1,179%
EBITDA-115.51M-52.49M220%
Gain YTD219.417-38.282-573%
P/E RatioN/A0.18-
Revenue00-
Total Cash103M57.6M179%
Total Debt8.29M24.7M34%
FUNDAMENTALS RATINGS
DBVT: Fundamental Ratings
DBVT
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DBVTPASG
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DBVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PASG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPTN26.48-0.03
-0.11%
SpartanNash Company
ARGX756.38-7.14
-0.94%
argenx SE
ISSC11.15-0.13
-1.15%
Innovative Solutions and Support
SKYW107.66-1.66
-1.52%
SkyWest
NAII3.50-0.09
-2.51%
Natural Alternatives International

DBVT and

Correlation & Price change

A.I.dvisor tells us that DBVT and CRDF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DBVT and CRDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBVT
1D Price
Change %
DBVT100%
-0.80%
CRDF - DBVT
32%
Poorly correlated
-1.44%
TAOX - DBVT
29%
Poorly correlated
+0.81%
GLSI - DBVT
29%
Poorly correlated
-1.66%
PASG - DBVT
26%
Poorly correlated
+0.43%
ALT - DBVT
26%
Poorly correlated
-1.36%
More

PASG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PASG has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PASG jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PASG
1D Price
Change %
PASG100%
+0.43%
AXON - PASG
43%
Loosely correlated
+0.67%
CYTK - PASG
38%
Loosely correlated
-4.11%
ARRY - PASG
35%
Loosely correlated
-2.29%
ANTX - PASG
33%
Poorly correlated
+0.79%
VYGR - PASG
32%
Poorly correlated
-4.57%
More